logologo
QuantliQuantli

Heron Therapeutics Inc

HRTX

NASDAQ

Biotechnology

$0.34

USD

0.00 (+0.69%)

At close: Aug 14, 2026, 4:00 PM EDT

Market Cap $63.49M

Volume 1.8M

Price Target

$2.00$2.00

USD

The 1 analysts offering 1-year price forecasts have a max estimate of $2.00 and a min estimate of $2.00.

Price (USD)
Price (USD)

Past 2Y

1Y Forecast

Price Targets

Average Target

$2.00

Implied Upside

+488.2%

Analyst Covering

1

Consensus

Buy

Signal Quality

Consensus Freshness

100%

Most ratings are recent - from the last 3 months

Analyst Agreement

High

Targets are closely clustered - analysts largely agree

Mean vs Median

$0 Gap

Median and average are closely aligned - few outliers skewing the consensus

Analyst Consensus

Strong Sell

Hold

Strong Buy

Buy

1 Buy

0 Hold

0 Sell

Rating Breakdown

Strong Buy

0

Buy

1

Hold

0

Sell

0

Strong Sell

0

1 analysts · last 3 months

Covering Analysts

Unlock each analyst's profile, success rate + price targets

Free shows the consensus and each analyst's current rating.

AnalystFirmRatingActionDateSuccess RatePrice TargetImplied Upside

Brandon Folkes

HC Wainwright & Co.

Hold

Downgraded

4 days ago

Plus
Plus
Plus

Serge Belanger

Needham

Hold

Downgraded

2 months ago

Plus
Plus
Plus

Frequently Asked Questions

Similar Stocks

BOLD

Boundless Bio Inc

$2.83

+2.0%

PMVP

PMV Pharmaceuticals Inc

$1.26

+3.7%

XLO

Xilio Therapeutics Inc

$9.17

+1.8%

DWTX

Dogwood Therapeutics Inc

$2.15

+8.6%

RNXT

RenovoRx Inc

$1.40

+11.1%

INMB

INmune Bio Inc

$2.17

+4.3%

ATYR

aTyr Pharma Inc

$0.5600

+1.1%

EXOZ

eXoZymes Inc

$5.82

-3.0%

INKT

Mink Therapeutics Inc

$11.27

+2.5%

MNOV

MediciNova Inc

$1.31

0.0%